BriaCell Therapeutics Corp. (BCT.TO)
5.91
-0.01
(-0.17%)
CAD |
TSX |
Sep 18, 16:00
BriaCell Therapeutics Price to Book Value : 1.309 for Sept. 18, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 1.309 |
| September 17, 2026 | 1.311 |
| September 16, 2026 | 1.103 |
| September 15, 2026 | 1.089 |
| September 14, 2026 | 1.103 |
| September 11, 2026 | 1.116 |
| September 10, 2026 | 1.105 |
| September 09, 2026 | 1.118 |
| September 08, 2026 | 1.074 |
| September 04, 2026 | 1.092 |
| September 03, 2026 | 1.078 |
| September 02, 2026 | 1.096 |
| September 01, 2026 | 1.118 |
| August 31, 2026 | 1.100 |
| August 28, 2026 | 1.149 |
| August 27, 2026 | 1.142 |
| August 26, 2026 | 1.244 |
| August 25, 2026 | 1.138 |
| August 24, 2026 | 1.067 |
| August 21, 2026 | 1.231 |
| August 20, 2026 | 1.213 |
| August 19, 2026 | 1.207 |
| August 18, 2026 | 1.074 |
| August 17, 2026 | 1.041 |
| August 14, 2026 | 1.047 |
| Date | Value |
|---|---|
| August 13, 2026 | 1.063 |
| August 12, 2026 | 1.050 |
| August 11, 2026 | 1.058 |
| August 10, 2026 | 1.045 |
| August 07, 2026 | 1.123 |
| August 06, 2026 | 1.074 |
| August 05, 2026 | 1.092 |
| August 04, 2026 | 1.043 |
| July 31, 2026 | 1.067 |
| July 30, 2026 | 1.129 |
| July 29, 2026 | 1.070 |
| July 28, 2026 | 1.076 |
| July 27, 2026 | 1.116 |
| July 24, 2026 | 1.114 |
| July 23, 2026 | 1.156 |
| July 21, 2026 | 1.160 |
| July 20, 2026 | 1.127 |
| July 17, 2026 | 1.165 |
| July 16, 2026 | 1.182 |
| July 15, 2026 | 1.222 |
| July 14, 2026 | 1.156 |
| July 13, 2026 | 1.180 |
| July 10, 2026 | 1.236 |
| July 09, 2026 | 1.145 |
| July 08, 2026 | 1.167 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Kane Biotech, Inc. | -- |
| Quest PharmaTech, Inc. | 0.16 |
| Vaxil Bio Ltd. | 0.4838 |
| Waverley Pharma, Inc. | -- |
| Goldcoast Resource Corp. | 3.240 |
Price to Book Value Related Metrics
| Price | 5.91 |
| Earnings Yield | -285.4% |
| Market Cap | 42.85M |